Related Experiment Video
Updated: Sep 13, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Association of Tumor Suppressor TP53 and TP21 Gene Polymoprhisms with Radiotherapy Induced Adverse Reactions in Head
Anand K Gudur1, Rashmi A Gudur1, Suresh J Bhosale1
1Department of Oncology, Krishna Vishwa Vidyapeeth "Deemed to be University", Taluka-Karad, Dist- Satara, Pin-415 539, (Maharashtra), India.
Background:
The current study was intended to analyze the genotype distribution of the tumor suppressor genes TP53 and TP21, and to investigate their potential association with acute radiotherapy -induced toxicities, such as skin reactions and mucositis, in normal tissues of head and neck cancer (HNC) patients receiving radiotherapy.
Materials & Methods:
Two hundred and fifty HNC patients undergoing radiotherapy were enrolled in this study and the acute toxicity reactions and radiotherapy response were recorded. The potential association of two single nucleotide polymorphisms (SNPs) (rs1042522, rs28934571) of TP53 gene and (rs1801270, rs1059234) SNPs of TP21 gene, with the risk of acute skin toxicity reactions was analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct DNA sequencing methods.
Results:
The findings revealed that the homozygous recessive (C/C) genotype of the 72G>C polymorphism in the TP53 gene exhibited a significantly increased association with acute skin toxicity in (HNC) patients undergoing radiotherapy (OR = 4.32, 95% CI: 1.87-10.01; p = 0.0006, and the heterozygous (G/C) genotype of the same polymorphism demonstrated a robust correlation with acute skin reactions (OR = 9.23, 95% CI: 4.40-19.23; p < 0.0001). The heterozygous variant (G/C) genotype of TP53 was identified as a significant risk factor for oral mucositis exceeding grade 2 severity in HNC patients receiving radiotherapy, with an odds ratio of 4.15 (95% CI: 2.21-7.76; p < 0.0001).
Conclusion:
The results of genetic polymorphisms of TP53 and TP21 genes and their association with radiotherapy induced acute toxicities demonstrated significant association of TP53, G72C polymorphism of rs1042522 SNP with both acute radiotherapy induced dermatitis and mucositis.
More Related Videos
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...